Equine arteritis virus

Theriogenology

Volumn 47, Issue 6, 1997, Pages 1275-1295

  Glaser, A L ^a   Chirnside, E D ^b,c   Horzinek, M C ^a   De Vries, A A F ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b ANIMAL HEALTH TRUST   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Control; Equine arteritis virus; Prevention; Review

Indexed keywords

EQUINE VIRAL ARTERITIS VIRUS; VACCINATION; VIRUS DETECTION; VIRUS INFECTION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ARVAC; LIVE VACCINE; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS VACCINE;

ABORTION; ANIMAL DISEASE; ANIMAL MODEL; ANTIBODY DETECTION; ARTICLE; BREEDING; ENZYME LINKED IMMUNOSORBENT ASSAY; EQUINE VIRAL ARTERITIS VIRUS; HORSE DISEASE; INFECTION CONTROL; NONHUMAN; RNA VIRUS; SERODIAGNOSIS; VACCINATION; VIRUS DETECTION; VIRUS GENOME; VIRUS INFECTION;

EID: 0031569436     PISSN: 0093691X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0093-691X(97)00107-6     Document Type: Article

References (114)

1. Balasuriya UBR, Rossitto PV, DeMaula CD, MacLachlan NJ. A 29K envelope glycoprotein of equine arteritis virus expresses neutralization determinants recognised by murine monoclonal antibodies. J Gen Virol 1993;74:2525-2529.
2. Balasuriya UBR, MacLachlan NJ, de Vries AAF, Rossitto PV, Rottier PJM. Identification of a neutralization site in the major envelope glycoprotein (GL) of equine arteritis virus. Virology 1995;207:518-527.
3. Balasuriya UBR, Timoney PJ, McCollum WH, MacLachlan NJ. Phylogenetic analysis of open reading frame 5 of field isolates of equine arteritis virus and identification of conserved and nonconserved regions in the GL envelope glycoprotein. Virology 1995;214:690-697.
4. Belák S, Ballagi-Pordány A, Timoney PJ, McCollum WH, Little TV, Hyllseth B, Klingeborn B. Evaluation of a nested PCR assay for the detection of equine arteritis virus infection. In: Nakajima H, Plowright W (eds), Proceedings of the 7th International Conference on Equine Infectious Diseases, Tokyo, 1994. Newmarket, R&W Publications, 1994;33-38.
5. Bergman AM. Beiträge zur Kenntnis der Virusträger bei Rotlaufseuche, Influenza erysipelatosa, des Pferdes. Zentralbl Infektionskrankh 1913;13:161-174.
6. Bürki F, Gerber H. Ein virologisch gesicherter Großausbruch von Equiner Arteritis. Berl Münch Tierärztl Wochenschr 1966;79:391-395.
7. Bürki F. The virology of equine arteritis virus. In: Bryans JT, Gerber H (eds), Proceedings of the 2nd International Conference on Equine Infectious Diseases, Paris, 1969. Basel, Karger, 1970;125-129.
8. Cancellotti FM, Renzi M. Equine arteritis virus (EAV) in Italy: current situation. In: Plowright W, Rossdale PD, Wade JF (eds), Proceedings of the 6th International Conference on Equine Infectious Diseases, Cambridge, 1991. Newmarket, R&W Publications, 1992;304.
9. Carman S, Rae C, Dubovi E. Equine arteritis virus isolated from a standardbred foal with pneumonia. Can Vet J 1988,29:937.
10. Cavanagh D, Brien DA, Brinton M, Enjuanes L, Holmes KV, Horzinek MC, Lai MMC, Laude H, Plagemann PGW, Siddell S, Spaan WJM, Taguchi F, Talbot PJ. Revision of the taxonomy of the Coronavirus, Torovirus and Arterivirus genera. Arch Virol 1994;135:227-237.
11. Chirnside ED, Cook RF, Lock MW, Mumford JA. Monoclonal antibodies to equine arteritis virus. In: Powell DG (ed), Proceedings of the 5th International Conference on Equine Infectious Diseases, Lexington, 1987. Lexington, The University Press of Kentucky, 1988;262-267.
12. Chirnside ED, Spaan WJM. Reverse transcription and cDNA amplification by the polymerase chain reaction of equine arteritis virus (EAV). J Virol Meth 1990;30:133-140.
13. Chirnside ED, Wearing CM, Binns MM, Mumford JA. Comparison of M and N gene sequences distinguishes variation amongst equine arteritis virus isolates. J Gen Virol 1994;75:1491-1497.
14. Chirnside ED, de Vries AAF, Mumford JA, Rottier PJM. Equine arteritis virus-neutralizing antibody in the horse is induced by a determinant on the large envelope glycoprotein GL. J Gen Virol 1995;76:1989-1998.
15. Chirnside ED, Francis PM, de Vries AAF, Sinclair R, Mumford JA. Development and evaluation of an ELISA using recombinant fusion protein to detect the presence of host antibody to equine arteritis virus. J Virol Meth 1995,54:1-13.
16. Chirnside ED, Francis PM, Mumford JA. Expression cloning and antigenic analysis of the nucleocapsid protein of equine arteritis virus. Virus Res 1995;39:277-288.
17. Clark I. Transmission of pink-eye from apparently healthy stallions to mares. J Comp Path 1892;5:261-264.
18. Clayton H. 1986 outbreak of EVA in Alberta, Canada. J Equine Vet Sci 1987;7:101.
19. Coignoul FL, Cheville NF. Pathology of the maternal genital tract, placenta and foetus in equine viral arteritis. Vet Pathol 1984;21:333-340.
20. Cole JR, Hall RF, Gosser HS, Hendricks JB, Pursell AR, Senne DA, Pearson JE, Gibson CA. Transmissibility and abortigenic effect of equine viral arteritis in mares. J Am Vet Med Assoc 1986;189:769-771.
21. Collins JK, Kari S, Ralston SL, Bennet DG, Traub Dargatz JL, McKinnon AO. Equine viral arteritis in a veterinary teaching hospital. Prevent Vet Med 1987;4:389-397.
22. Cook RF, Gann SJ, Mumford JA. The effects of vaccination with tissue culture-derived viral vaccines on detection of antibodies to equine arteritis virus by enzyme-linked immunosorbent assay (ELISA). Vet Microbiol 1989,20:181-189.
23. Crawford TB, Henson JB. Immunofluorescent, light-microscopic and immunologic studies of equine viral arteritis. In: Bryans JT, Gerber H (eds), Proceedings of the 3rd International Conference on Equine Infectious Diseases, Paris, 1972. Basel, Karger, 1973;282-302.
24. Del Piero F, Wilkins PA, Lopez J, Glaser A, Dubovi EJ, Schlafer DH, Lein D. Equine arteritis in newborn foals: clinical, pathological, serological, microbiological and immunoperoxidase histochemical findings. Submitted to Equine Vet J.
25. den Boon JA, Snijder EJ, Chirnside ED, de Vries AAF, Horzinek MC, Spaan WJM. Equine arteritis virus is not a togavirus but belongs to the coronavirus-like superfamily. J Virol 1991;65;2910-2920.
26. den Boon JA, Faaberg KS, Meulenberg JJM, Wassenaar ALM, Plagemann PGW, Gorbalenya AE, Snijder EJ. Processing and evolution of the N-terminal region of the arterivirus replicase ORF1a protein: identification of two papainlike cysteine proteases. J Virol 1995;69:4500-4505.
27. Deregt D, de Vries AAF, Raamsman MJB, Elmgren LD, Rottier PJM. Monoclonal antibodies to equine arteritis virus identify the GL protein as a target for virus neutralization. J Gen Virol 1994;75:2439-2444.
28. de Vries AAF, Chirnside ED, Bredenbeek PJ, Gravestein LA, Horzinek MC, Spaan WJM. All subgenomic mRNAs of equine arteritis virus contain a common leader sequence. Nucl Acids Res 1990;18:3241-3247.
29. de Vries AAF, Chirnside ED, Horzinek MC, Rottier PJM. Structural proteins of equine arteritis virus. J Virol 1992;66:6294-6303.
30. de Vries AAF. The molecular biology of equine arteritis virus. Ph.D. thesis, Utrecht University, Utrecht, 1994.
31. Doll ER, Bryans JT, McCollum WH, Crowe M. Isolation of a filterable agent causing arteritis of horses and abortion by mares. Its differentiation from the equine abortion (influenza) virus. Cornell Vet 1957;47:3-41.
32. Doll ER, Knappenberger RE, Bryans JT. An outbreak of abortion caused by the equine arteritis virus. Cornell Vet 1957;47:69-75.
33. Doll ER, Bryans JT, Wilson JC, McCollum WH. Immunisation against equine viral arteritis using modified live virus propagated in cell cultures of rabbit kidney. Cornell Vet 1968;58:497-524.
34. Eichhorn W, Heilmann M, Kaaden O-R. Equine viral arteritis with abortions: serological and virological evidence in Germany. J Vet Med Ser B 1995;42:573-576.
35. European Community Publication 1995;April 24:No. L 117/27
36. Fukunaga Y, McCollum WH. Complement fixation reactions in equine viral arteritis. Am J Vet Res 1977;38:2043-2046.
37. Fukunaga Y, Wada R, Hirasawa K, Kamada M, Kumanomido T, Akiyama Y. Effect of the modified Bucyrus strain of equine arteritis virus experimentally inoculated into horses. Bull Equine Res Inst 1982;19:97-101.
38. Fukunaga Y, Wada R, Kamada M, Kumanomido T, Akiyama Y. Tentative preparation of an inactivated virus vaccine for equine viral arteritis. Bull Equine Res Inst 1984,21:56-64.
39. Fukunaga Y, Wada R, Matsumura T, Sugiura T, Imagawa H. Induction of immune response and protection from equine viral arteritis (EVA) by formalin-inactivated virus vaccine for EVA in horses. J Vet Med Ser B 1990;37:135-141.
40. Fukunaga Y, Wada R, Matsumura T, Anzai T, Imagawa H, Sugiura T, Kumanomido T, Kanemaru T, Kamada M. An attempt to protect against persistent infection of equine viral arteritis in the reproductive tract of stallions using formalin-inactivated virus vaccine. In: Plowright W, Rossdale PD, Wade JF (eds), Proceedings of the 6th International Conference on Equine Infectious Diseases, Cambridge, 1991. Newmarket, R&W Publications, 1992;239-244.
41. Fukunaga Y, Matsumura T, Sugiura T, Wada R, Imagawa H, Kanemaru T, Kamada M. Use of the serum neutralisation test for equine viral arteritis with different virus strains. Vet Rec 1994;134:574-576.
42. Fukunaga Y, Wada R, Kanemaru T, Imagawa H, Kamada M. Failure in the development of carrier state of equine viral arteritis in colts. J Equine Sci 1994;5:45-48.
43. Fukunaga Y, Wada R, Kanemaru T, Imagawa H, Kamada M, Samejima T. Protection against abortion in pregnant mares vaccinated with a killed vaccine after exposure to equine arteritis virus. In: Nakajima H, Plowright W (eds), Proceedings of the 7th International Conference on Equine Infectious Diseases, Tokyo, 1994. Newmarket, R&W Publications, 1994;340.
44. Gerber H, Steck F, Hofer B, Walther L, Friedli U. Serological investigations on equine viral arteritis. In: Bryans JT, Gerber H (eds), Proceedings of the 4th International Conference on Equine Infectious Diseases, Lyon, 1976. Princeton, Veterinary Publications Inc., 1978;461-465.
45. Glaser AL, de Vries AAF, Dubovi EJ. Comparison of equine arteritis virus isolates using neutralizing monoclonal antibodies and identification of sequence changes in GL associated with neutralization resistance. J Gen Virol 1995;76:2223-2233.
46. Golnik W, Michalak T. Przypadki wirusowego zapalenia tetnic koni (arteritis equroum) w Polsce. Med Weterynaryjna 1979;35:605-606.
47. Golnik W, Michalska Z, Michalak T. Natural viral arteritis in foals. Schweiz Arch Tierheilk 1981;123:523-533.
48. Golnik W, Moraillon A, Golnik J. Identification and antigenic comparison of equine arteritis virus isolated from an outbreak of epidemic abortion of mares. J Vet Med Ser B 1986;33:413-417.
49. Golnik W. Viruses isolated from aborted foetuses and stillborn foals. In: Plowright W, Rossdale PD, Wade JF (eds), Proceedings of the 6th International Conference on Equine Infectious Diseases, Cambridge, 1991. Newmarket, R&W Publications, 1992;314.
50. Harry TO, McCollum WH. Stability of viability and immunising potency of lyophilised, modified equine arteritis live virus vaccine. Am J Vet Res 1981;42:1501-1505.
51. Himeur D. Incidence au maroc de l'anemie infectieuse, de la rhinopneumonie, de l'arterite a virus des equides - enquete epidemiologique - prophylaxie. Ph.D. thesis, Ecole Nationale Veterinaire d'Alfort, Maisons-Alfort, 1975.
52. Holyoak GR, Little TV, McCollum WH, Timoney PJ. Relationship between onset of puberty and establishment of persistent infection with equine arteritis virus in the experimentally infected colt. J Comp Path 1993;109:29-46.
53. Horzinek MC. Non-arthropod-borne Togaviruses. London, Academic Press, 1981;30-31.
54. Huntington PJ, Forman AJ, Ellis PM. The occurence of equine arteritis virus in Australia. Aust Vet J 1990;67:432-435.
55. Hyllseth B, Petersson U. Neutralisation of equine arteritis virus; enhancing effect of guinea pig serum. Arch Gesamte Virusforsch 1970;32:337-347.
56. Johnson B, Baldwin C, Timoney P, Ely R. Arteritis in equine fetuses aborted due to equine viral arteritis. Vet Pathol 1991;28:248-250.
57. Klingeborn B, Wahlström H, Wierup M, Ballagi-Pordány A, Belák S. Prevalence of antibodies to equine arteritis virus in Sweden, shedding of the virus in semen from Swedish breeding stallions and evaluation of its possible influence on fertility. In: Plowright W, Rossdale PD, Wade JF (eds), Proceedings of the 6th International Conference on Equine Infectious Diseases, Cambridge, 1991. Newmarket, R&W Publications, 1991;319-320.
58. Lang G, Mitchell WR. A serosurvey by ELISA for antibodies to EAV in Ontario racehorses. J Equine Vet Sci 1984;4:153-157.
59. Little TV, Holyoak GR, McCollum WH, Timoney PJ. Output of equine arteritis virus from persistently infected stallions is testosterone-dependent. In: Plowright W, Rossdale PD, Wade JF (eds), Proceedings of the 6th International Conference on Equine Infectious Diseases, Cambridge, 1991. Newmarket, R&W Publications, 1992;225-229.
60. Little TV, Deregt D, McCollum WH, Timoney PJ. Evaluation of an immunohistochemical method for rapid detection and identification of equine arteritis virus in natural cases of infection. In: Nakajima H, Plowright W (eds), Proceedings of the 7th International Conference on Equine Infectious Diseases, Tokyo, 1994. Newmarket, R&W Publications, 1994;27-31.
61. Lopez JW, Del Piero F, Glaser A, Finazzi M. Immunoperoxidase histochemistry as a diagnostic tool for detection of equine arteritis virus antigen in formalin fixed tissues. Equine Vet J 1996;28:77-79.
62. Magnusson P, Hyllseth B, and Marusyk H. Morphological studies on equine arteritis virus. Arch Gesamte Virusforsch 1970;30:105-112.
63. Matumoto M, Shimizu T, Ishizaki R. Constat anticorps contre le virus de l'artérite équine dans le serum de juments indiennes. C R Soc Biol 1965;159:1262-1264.
64. McCollum WH, Doll ER, Wilson JC, Johnson CB. Propagation of equine arteritis virus in monolayer cultures of equine kidney. Am J Vet Res 1961;22:731-735.
65. McCollum WH, Doll ER, Wilson JC. The recovery of virus from horses with experimental cases of equine arteritis using monolayer cell cultures of equine kidney. Am J Vet Res 1962;23:465-469.
66. McCollum WH. Development of a modified virus strain and vaccine for equine viral arteritis. J Am Vet Med Assoc 1969;155:318-322.
67. McCollum WH. Vaccination for equine arteritis virus. In: Bryans JT, Gerber H (eds). Proceedings of the 2nd International Conference on Equine Infectious Diseases, Paris, 1969. Basel, Karger, 1970;143-151.
68. McCollum WH, Prickett ME, Bryans JT. Temporal distribution of equine arteritis virus in respiratory mucosa, tissues and body fluids of horses infected by inhalation. Res Vet Sci 1971;12:459-464.
69. McCollum WH, Bryans JT. Serological identification of infection by equine arteritis virus in horses of several countries. In: Proceedings of the 3rd International Conference on Equine Infectious Diseases, Paris, 1972. Basel, Karger, 1973;256-263.
70. McCollum WH. Studies of passive immunity in foals to equine viral arteritis. Vet Microbiol 1976;1:45-54.
71. McCollum WH, Swerczek TW. Studies of an epizootic of equine viral arteritis in racehorses. Equine Vet J 1978;2:293-299.
72. McCollum WH. Pathological features of horses given avirulent virus intramuscularly. Am J Vet Res 1981;42:1218-1220.
73. McCollum WH, Timoney PJ. The pathogenic qualities of the 1984 strain of equine arteritis virus. In: Proceedings of the Grayson Foundation International Conference of Thoroughbred Breeders Organizations. Dromoland Castle, 1984;34-84.
74. McCollum WH. Responses of horses vaccinated with avirulent modified-live equine arteritis virus propagated in E. Derm (NBL-6) cell line to nasal inoculations with virulent virus. Am J Vet Res 1986;47:1931-1934.
75. McCollum WH, Timoney PJ, Roberts AW, Willard JE, Carswell GD. Response of vaccinated and non-vaccinated mares to artificial insemination with semen from stallions persistently infected with equine arteritis virus. In: Powell DG (ed), Proceedings of the 5th International Conference on Equine Infectious Diseases, Lexington, 1987 Lexington, The University Press of Kentucky, 1988;13-18.
76. McCollum WH, Little TV, Timoney PJ, Swerczek TW. Resistance of castrated male horses to attempted establishment of the carrier state with equine arteritis virus. J Comp Path 1994;111:383-388.
77. McCollum WH, Timoney PJ, Tengelson LA. Clinical, virological and serological responses of donkeys to intranasal inoculations with the KY-84 strain of equine arteritis virus. J Comp Path 1995;112:207-211.
78. McKinnon AO, Colbern GT, Collins JK, Bowen RA, Voss JL, Umphenour JW. Vaccination of stallions with a modified live equine arteritis virus vaccine. J Equine Vet Sci 1986;6:66-69.
79. Moraillon R, Moraillon A. Results of a serological survey of viral arteritis in France and several European and African countries. In: Bryans JT, Gerber H (eds), Proceedings of the 4th International Conference on Equine Infectious Diseases, Lyon, 1976. Princeton, Veterinary Publications Inc, 1978;467-474.
80. Moraillon A, Moraillon R, Toma B, Sedrati A, Lahlou-Kassi S. Enquête épidémiologique sur l'anémie infectieuse, la rhinopneumonie et l'artérite a virus des équidés au Maroc. Recl Méd Vét 1978;154:921-928.
81. Murphy FA. Togavirus morphology and morphogenesis. In: Schlesinger RW (ed), The Togaviruses: biology, structure and replication. New York, Academic Press, 1980;241-316.
82. Neu SM, Timoney PJ, McCollum WH. Persistent infection of the reproductive tract in stallions persistently infected with equine arteritis virus. In: Powell DG (ed), Proceedings of the 5th International Conference on Equine Infectious Diseases. Lexington, 1987. Lexington, The University Press of Kentucky, 1988;149-154.
83. Neu SM, Timoney PJ, Lowry SR. Changes in semen quality in the stallion following experimental infection with equine arteritis virus. Theriogenology 1992;37:407-431.
84. Nowotny N. First isolation of equine arteritis virus (EAV) from three aborted equine foetuses from three different premises in Austria. In: Plowright W, Rossdale PD, Wade JF (eds), Proceedings of the 6th International Conference on Equine Infectious Diseases, Cambridge, 1991. Newmarket, R&W Publications, 1992;328.
85. Paweska JT, Barnard BJH. Serological evidence of equine arteritis virus in donkeys in South Africa. Onderstepoort J Vet Res 1993;60:155-158.
86. Paweska JT. An epidemiological investigation of equine viral arteritis in donkeys in South Africa. In: Nakajima H, Plowright W (eds), Proceedings of the 7th International Conference on Equine Infectious Diseases, Tokyo, 1994. Newmarket, R&W Publications, 1994;337-338.
87. Paweska JT. Equine viral arteritis. J S Afr Vet Assoc 1995;66:111-112.
88. Paweska JT, Volkmann DH, Barnard BJH, Chirnside ED. Sexual and in-contact transmission of asinine strain of equine arteritis virus among donkeys. J Clin Microbiol 1995;33:3296-3299.
89. Paweska JT, Binns MM, Woods PSA, Chirnside ED. A survey for antibodies to equine arteritis virus in donkeys, mules and zebra using virus neutralisation (VN) and enzyme linked immunosorbent assay (ELISA). Submitted to Equine Vet J.
90. Porterfield JS, Casals J, Chumakov MP, Gaidamovich SYa, Hannoun C, Holmes IH, Horzinek MC, Mussgay M, Oker-Blom N, Russel PK, Trent DW. Togaviridae. Intervirology 1978;9:129-148.
91. Pottie A. The propagation of influenza from stallions to mares. J. Comp Path 1888;1:37-38.
92. Sekiguchi K, Sugita S, Fukunaga Y, Kondo T, Wada R, Kamada M, Yamaguchi S. Detection of equine arteritis virus (EAV) by the polymerase chain reaction (PCR) and differentiation of EAV isolates by restriction enzyme analysis of PCR products. In Nakajima H, Plowright W (eds), Proceedings of the Seventh International Conference on Equine Infectious Diseases, Tokyo, 1994. Newmarket, R&W Publications, 1994;338.
93. Senne DA, Pearson JE, Carbrey EA. Equine viral arteritis: a standard procedure for the virus neutralisation test and comparison of results of a proficiency test performed at five laboratories. In: Proceedings of the 89th Annual Meeting of the United States Animal Health Association, Milwaukee, 1985;29-34.
94. Snijder EJ, Wassenaar ALM, Spaan WJM. The 5′ end of the equine arteritis virus replicase gene encodes a papainlike cysteine protease. J Virol 1992,66:7040-7048.
95. Snijder EJ, Wassenaar ALM, Spaan WJM, Gorbalenya AE. The arterivirus Nsp2 protease. An unusual cysteine protease with primary structure similarities to both papain-like and chymotrypsin-like proteases. J Biol Chem 1995;270:16671-16676.
96. St-Laurent G, Morin G, Archambault D. Detection of equine arteritis virus following amplification of structural and nonstructural viral genes by reverse transcription-PCR. J Clin Microbiol 1994;32:658-665.
97. Sugita S, Kondo T, Sekiguchi K, Yamaguchi S, Kamada M, Nerome K, Fukunaga Y. Molecular evolution of the M gene of equine arteritis virus. In: Nakajima H, Plowright W (eds), Proceedings of the 7th International Conference on Equine Infectious Diseases, Tokyo, 1994. Newmarket, R&W Publications, 1994;39-43.
98. Timoney PJ. Clinical, virological and epidemiological features of the 1984 outbreak of equine viral arteritis in the Thoroughbred population in Kentucky, USA. In: Proceedings of the Grayson Foundation International Conference of Thoroughbred Breeders Organizations, Dromoland Castle, 1984;24-33.
99. Timoney PJ, McCollum WH. The epidemiology of equine arteritis virus. Proc Am Assoc Equine Pract 1985;31:545-551.
100. Timoney PJ, McCollum WH, Roberts AW, Murphy TW. Demonstration of the carrier state in naturally acquired equine arteritis virus infection in the stallion. Res Vet Sci 1986;41:279-280.
101. Timoney PJ, McCollum WH, Murphy TW, Roberts AW, Willard AW, Carswell JG. The carrier state in equine arteritis virus infection in the stallion with specific emphasis on the venereal mode of transmission. J Reprod Fertil 1987;35(Suppl):95-102.
102. Timoney PJ, McCollum WH, Roberts AW, McDonald MJ. Status of equine arteritis virus in Kentucky, 1985. J Am Vet Med Assoc 1987;191:36-39.
103. Timoney PJ, McCollum WH. Equine viral arteritis: epidemiology and control. J Equine Vet Sci 1988;8:54-59.
104. Timoney PJ, Umphenour NW, McCollum WH. Safety evaluation of a commercial modified live equine arteritis virus vaccine for use in stallions. In: Powell DG (ed), Proceedings of the 5th International Conference on Equine Infectious Diseases, Lexington, 1987. Lexington, The University Press of Kentucky, 1988;19-27.
105. Timoney PJ, McCollum WH. Equine viral arteritis. Vet Clin North Am Equine Prac 1993;9:295-309.
106. Vaala WE, Hamir AN, Dubovi, EJ, Timoney PJ, Ruiz B. Fatal, congenitally acquired infection with equine arteritis virus in a neonatal Thoroughbred. Equine Vet J 1992;24:155-158.
107. van Berlo MF, Horzinek MC, van der Zeijst BAM. Equine arteritis virus-infected cells contain six polyadenylated virus-specific RNAs. Virology 1982;118:345-352.
108. van Berlo MF, Rottier PJM, Horzinek MC, van der Zeijst BAM. Intracellular equine arteritis virus (EAV)-specific RNAs contain common sequences. Virology 1986;152:492-496.
109. van Berlo MF, Rottier PJM, Spaan WJM, Horzinek MC. Equine arteritis virus-induced polypeptide synthesis. J Gen Virol 1986;67:1543-1549.
110. Wada R, Kondo T, Fukunaga Y, Kanemaru T. Histopathological and immunofluorescent studies on the uterus of aborted mares experimentally infected with equine arteritis virus. J Equine Sci 1995;5:41-43.
111. Weiss M, Ferrari L, Weibel-Attenberg P, Marti E, Burger D, Meier HP, Gerber H. Equine viral arteritis in Switzerland: a seroepidemiological survey. In: Nakajima H, Plowright W (eds), Proceedings of the 7th International Conference on Equine Infectious Diseases, Tokyo, 1994. Newmarket, R&W Publications, 1994;45-51.
112. Westaway EG, Brinton MA, Gaidamovich SYa, Horzinek MC, Igarashi A, Kääriäinen L, Lvov DK, Porterfield JS, Russell PK, Trent DW. Togaviridae. Intervirology 1985;24:125-139.
113. Westcott D, Lucas M, Paton D. Equine arteritis virus: antigenic analysis of strain variation. In: Schwyzer M, Ackermann M, Bertoni G, Kocherhans R, McCullough K, Engels M, Wittek R, Zanoni R (eds), Immunobiology of viral infections, Proceedings of the 3rd Congress of the European Society for Veterinary Virology, Interlaken, 1994. Lyon, Fondation Marcel Mérieux, 1995;479-483.
114. Wood JLN, Chirnside ED, Mumford JA, Higgins AJ. First recorded outbreak of equine viral arteritis in the United Kingdom. Vet Rec 1995;136:381-385.